Translating science into innovative diagnostic solutions


Motion Intelligence Inc. is now Quadrant Biosciences Inc.

We believe the name change better reflects the expanding scope of our research and business interests in the areas of functional assessment and epigenetic diagnostics. What started as a company focused on concussion management has quickly blossomed into a diversified translational medicine venture, with a world class epigenetic bioinformatics platform and active projects in such areas as ASD, geriatric fall risk, Parkinson’s Disease, ADHD, and the gut microbiome.

Better assessment tools mean healthier adults and kids

The difference is in the tools for diagnosis. Quadrant Biosciences works with top academic institutions, medical researchers and engineers to translate breakthrough findings into thoughtfully developed and scientifically sound assessment applications.

Our evolutionary advancements in brain health assessment, autism and Parkinson’s detection, will have a significant impact on the way clinicians approach the diagnosis and treatment of these serious conditions going forward. Supported through private and state funding, one of these key technologies, ClearEdge, is currently available in the market and the others are slated for a 2018 release.  


Quadrant Biosciences is pleased to have been selected as a StartupNY company.

Our Research Partners

Screen Shot 2017 05 08 At 5 01 57 Pm

Quadrant Biosciences is likewise pleased to be associated with several highly regarded research and educational institutions.